Tutorials
TSX:PRM.PR.A.PFD (Canada)  
Big Pharma Split Corp logo

Big Pharma Split Corp

(Preferred)
C$ 10.02 (-0.2%) Aug 12
P/E:
4.40
P/B:
0.96
Market Cap:
C$ - ($ -)
Enterprise V:
C$ - ($ 15.63M)
Volume:
3.00K
Avg Vol (2M):
3.36K
Volume:
3.00K
Market Cap C$:
-
Market Cap $:
-
PE Ratio:
4.40
Avg Vol (2-Month):
3.36K
Enterprise Value C$:
-
Enterprise Value $:
15.63M
PB Ratio:
0.96
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Big Pharma Split Corp
NAICS : 523930 SIC : 7214
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Description
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.59
Debt-to-EBITDA N/A
N/A
N/A
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 33.85
9-Day RSI 38.31
14-Day RSI 40.37
6-1 Month Momentum % -1.13
12-1 Month Momentum % 1.26

Liquidity Ratio

Name Current Vs Industry Vs History

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0
EPS (TTM) (C$) 0
Beta 0.14
Volatility % 4.8
14-Day RSI 40.37
14-Day ATR (C$) 0.059561
20-Day SMA (C$) 10.08
12-1 Month Momentum % 1.26
52-Week Range (C$) 10 - 10.99
Shares Outstanding (Mil) 0

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Big Pharma Split Corp Filings

Document Form Filing Date
No Filing Data